{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T21:21:23Z","timestamp":1781904083372,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11592-6","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:57:24Z","timestamp":1773320244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Curcumin nanoformulations in drug-resistant epilepsy: A mini review on mechanisms, preclinical evidence, and translational challenges"],"prefix":"10.1007","volume":"53","author":[{"given":"Amir Modarresi","family":"Chahardehi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Abedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryan","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Nozari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Khoshkholgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"2","key":"11592_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000503831","volume":"54","author":"E Beghi","year":"2020","unstructured":"Beghi E (2020) The epidemiology of epilepsy. Neuroepidemiology 54(2):185\u2013191. https:\/\/doi.org\/10.1159\/000503831","journal-title":"Neuroepidemiology"},{"issue":"10172","key":"11592_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs RD, Surges R, O\u2019Brien TJ, Sander JW (2019) Epilepsy in adults. Lancet 393(10172):689\u2013701. https:\/\/doi.org\/10.1016\/S0140-6736(18)32596-0","journal-title":"Lancet"},{"issue":"2","key":"11592_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1212\/CON.0000000000001081","volume":"28","author":"F Brigo","year":"2022","unstructured":"Brigo F, Marson A (2022) Approach to the medical treatment of epilepsy. Continuum (Minneap Minn) 28(2):483\u2013499. https:\/\/doi.org\/10.1212\/CON.0000000000001081","journal-title":"Continuum (Minneap Minn)"},{"issue":"6","key":"11592_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 51(6):1069\u20131077. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02397.x","journal-title":"Epilepsia"},{"key":"11592_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118826","volume":"265","author":"E Akyuz","year":"2021","unstructured":"Akyuz E, Polat AK, Eroglu E et al (2021) Revisiting the role of neurotransmitters in epilepsy: an updated review. Life Sci 265:118826. https:\/\/doi.org\/10.1016\/j.lfs.2020.118826","journal-title":"Life Sci"},{"key":"11592_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114786","volume":"193","author":"JL Green","year":"2021","unstructured":"Green JL, Dos Santos WF, Fontana ACK (2021) Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: opportunities for novel therapeutics development. Biochem Pharmacol 193:114786. https:\/\/doi.org\/10.1016\/j.bcp.2021.114786","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"11592_CR7","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.tips.2024.09.004","volume":"45","author":"D Debanne","year":"2024","unstructured":"Debanne D, Mylonaki K, Musella ML, Russier M (2024) Voltage-gated ion channels in epilepsies: circuit dysfunctions and treatments. Trends Pharmacol Sci 45(11):1018\u20131032. https:\/\/doi.org\/10.1016\/j.tips.2024.09.004","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"11592_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","volume":"15","author":"A Vezzani","year":"2019","unstructured":"Vezzani A, Balosso S, Ravizza T (2019) Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol 15(8):459\u2013472. https:\/\/doi.org\/10.1038\/s41582-019-0217-x","journal-title":"Nat Rev Neurol"},{"key":"11592_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1505867","volume":"15","author":"D Ji","year":"2025","unstructured":"Ji D, Mylvaganam S, Chander PR et al (2025) Mitochondria and oxidative stress in epilepsy: advances in antioxidant therapy. Front Pharmacol 15:1505867. https:\/\/doi.org\/10.3389\/fphar.2024.1505867","journal-title":"Front Pharmacol"},{"key":"11592_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","volume":"72","author":"W L\u00f6scher","year":"2020","unstructured":"L\u00f6scher W, Potschka H, Sisodiya SM, Vezzani A (2020) Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev 72:606\u2013638. https:\/\/doi.org\/10.1124\/pr.120.019539","journal-title":"Pharmacol Rev"},{"key":"11592_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.biomaterials.2018.09.040","volume":"188","author":"C Bennett","year":"2019","unstructured":"Bennett C, Mohammed F, \u00c1lvarez-Ciara A et al (2019) Neuroinflammation, oxidative stress, and blood-brain barrier (BBB) disruption in acute Utah electrode array implants and the effect of deferoxamine as an iron chelator on acute foreign body response. Biomaterials 188:144\u2013159. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.09.040","journal-title":"Biomaterials"},{"key":"11592_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-023-00745-5","volume":"18","author":"E Hu","year":"2023","unstructured":"Hu E, Li Z, Li T, Yang X, Ding R, Jiang H, Su H, Cheng M, Yu Z, Li H, Tang T (2023) A novel microbial and hepatic biotransformation-integrated network pharmacology strategy explores the therapeutic mechanisms of bioactive herbal products in neurological diseases: the effects of Astragaloside IV on intracerebral hemorrhage as an example. Chin Med 18:40. https:\/\/doi.org\/10.1186\/s13020-023-00745-5","journal-title":"Chin Med"},{"key":"11592_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.neuroscience.2015.09.058","volume":"310","author":"Z Jiang","year":"2015","unstructured":"Jiang Z, Guo M, Shi C et al (2015) Protection against cognitive impairment and modification of epileptogenesis with curcumin in a post-status epilepticus model of temporal lobe epilepsy. Neuroscience 310:362\u2013371. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.09.058","journal-title":"Neuroscience"},{"issue":"4","key":"11592_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1055\/a-1948-4378","volume":"89","author":"K Slowing","year":"2023","unstructured":"Slowing K, Gomez F, Delgado M et al (2023) PET imaging and neurohistochemistry reveal that curcumin attenuates brain hypometabolism and hippocampal damage induced by status epilepticus in rats. Planta Med 89(4):364\u2013376. https:\/\/doi.org\/10.1055\/a-1948-4378","journal-title":"Planta Med"},{"issue":"2","key":"11592_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biom9020056","volume":"9","author":"ML Del Prado-Audelo","year":"2019","unstructured":"Del Prado-Audelo ML, Caballero-Flor\u00e1n IH, Meza-Toledo JA et al (2019) Formulations of curcumin nanoparticles for brain diseases. Biomolecules 9(2):56. https:\/\/doi.org\/10.3390\/biom9020056","journal-title":"Biomolecules"},{"key":"11592_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejmech.2018.12.016","volume":"163","author":"B Salehi","year":"2019","unstructured":"Salehi B, Stojanovi\u0107-Radi\u0107 Z, Mateji\u0107 J et al (2019) The therapeutic potential of curcumin: a review of clinical trials. Eur J Med Chem 163:527\u2013545. https:\/\/doi.org\/10.1016\/j.ejmech.2018.12.016","journal-title":"Eur J Med Chem"},{"issue":"Pt B","key":"11592_CR17","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.pnpbp.2017.07.025","volume":"79","author":"M Hashemian","year":"2017","unstructured":"Hashemian M, Anissian D, Ghasemi-Kasman M et al (2017) Curcumin-loaded chitosan-alginate-STPP nanoparticles ameliorate memory deficits and reduce glial activation in pentylenetetrazol-induced kindling model of epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 79(Pt B):462\u2013471. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.07.025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"11592_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.22037\/ijcn.v15i4.28648","volume":"16","author":"M Erfani","year":"2022","unstructured":"Erfani M, Ashrafzadeh F, Rahimi HR et al (2022) Effect of curcumin on pediatric intractable epilepsy. Iran J Child Neurol 16(3):35\u201345. https:\/\/doi.org\/10.22037\/ijcn.v15i4.28648","journal-title":"Iran J Child Neurol"},{"key":"11592_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6687185","volume":"2020","author":"N Yang","year":"2020","unstructured":"Yang N, Guan QW, Chen FH et al (2020) Antioxidants targeting mitochondrial oxidative stress: promising neuroprotectants for epilepsy. Oxid Med Cell Longev 2020:6687185. https:\/\/doi.org\/10.1155\/2020\/6687185","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"11592_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14010071","volume":"14","author":"APA Boleti","year":"2024","unstructured":"Boleti APA, Cardoso PHO, Frihling BEF et al (2024) Pathophysiology to risk factor and therapeutics to treatment strategies on epilepsy. Brain Sci 14(1):71. https:\/\/doi.org\/10.3390\/brainsci14010071","journal-title":"Brain Sci"},{"key":"11592_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neuint.2015.07.009","volume":"89","author":"H Kaur","year":"2015","unstructured":"Kaur H, Patro I, Tikoo K, Sandhir R (2015) Curcumin attenuates inflammatory response and cognitive deficits in experimental model of chronic epilepsy. Neurochem Int 89:40\u201350. https:\/\/doi.org\/10.1016\/j.neuint.2015.07.009","journal-title":"Neurochem Int"},{"key":"11592_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/978-3-030-56153-6_21","volume":"1291","author":"F Forouzanfar","year":"2021","unstructured":"Forouzanfar F, Majeed M, Jamialahmadi T, Sahebkar A (2021) Curcumin: a review of its effects on epilepsy. Adv Exp Med Biol 1291:363\u2013373. https:\/\/doi.org\/10.1007\/978-3-030-56153-6_21","journal-title":"Adv Exp Med Biol"},{"key":"11592_CR23","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.18502\/ijph.v48i7.2960","volume":"48","author":"F Safavifar","year":"2019","unstructured":"Safavifar F, Saadat F, Jalali SZ, Khoramizadeh MR (2019) Augmented cAMP signaling by co-administration of resveratrol and curcumin: a cellular biosensor kinetic assessment. Iran J Public Health 48:1310\u20131316. https:\/\/doi.org\/10.18502\/ijph.v48i7.2960","journal-title":"Iran J Public Health"},{"key":"11592_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2174\/1567202615666180731100224","volume":"15","author":"Q He","year":"2018","unstructured":"He Q, Jiang L, Man S, Wu L, Hu Y, Chen W (2018) Curcumin reduces neuronal loss and inhibits the NLRP3 inflammasome activation in an epileptic rat model. Curr Neurovasc Res 15:186\u2013192. https:\/\/doi.org\/10.2174\/1567202615666180731100224","journal-title":"Curr Neurovasc Res"},{"issue":"1\u20132","key":"11592_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drudis.2011.09.009","volume":"17","author":"MM Yallapu","year":"2012","unstructured":"Yallapu MM, Jaggi M, Chauhan SC (2012) Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 17(1\u20132):71\u201380. https:\/\/doi.org\/10.1016\/j.drudis.2011.09.009","journal-title":"Drug Discov Today"},{"issue":"7","key":"11592_CR26","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1080\/00498254.2022.2136044","volume":"52","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Lv Y, Hu M, Guo F, Zhang C (2022) Curcumin-loaded hydroxypropyl-\u03b2-cyclodextrin inclusion complex with enhanced dissolution and oral bioavailability for epilepsy treatment. Xenobiotica 52(7):718\u2013728. https:\/\/doi.org\/10.1080\/00498254.2022.2136044","journal-title":"Xenobiotica"},{"key":"11592_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022822","volume":"5","author":"A Pitk\u00e4nen","year":"2015","unstructured":"Pitk\u00e4nen A, Lukasiuk K, Dudek FE, Staley KJ (2015) Epileptogenesis. Cold Spring Harb Perspect Med 5:a022822. https:\/\/doi.org\/10.1101\/cshperspect.a022822","journal-title":"Cold Spring Harb Perspect Med"},{"key":"11592_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.24","volume":"4","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Vezzani A, O\u2019Brien TJ, Jette N, Scheffer IE, de Curtis M, Perucca P (2018) Epilepsy. Nat Rev Dis Primers 4:18024. https:\/\/doi.org\/10.1038\/nrdp.2018.24","journal-title":"Nat Rev Dis Primers"},{"key":"11592_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-02053-w","author":"SM Razavi","year":"2025","unstructured":"Razavi SM, Najafi Arab Z, Hosseini Y et al (2025) Therapeutic effects of curcumin on seizure and its mechanisms of action. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-025-02053-w","journal-title":"Inflammopharmacology"},{"issue":"10","key":"11592_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101715","volume":"13","author":"R Tabanelli","year":"2021","unstructured":"Tabanelli R, Brogi S, Calderone V (2021) Improving curcumin bioavailability: current strategies and future perspectives. Pharmaceutics 13(10):1715. https:\/\/doi.org\/10.3390\/pharmaceutics13101715","journal-title":"Pharmaceutics"},{"issue":"13","key":"11592_CR31","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1021\/acschemneuro.0c00242","volume":"11","author":"R Huang","year":"2020","unstructured":"Huang R, Zhu Y, Lin L, Song S, Cheng L, Zhu R (2020) Solid lipid nanoparticles enhanced the neuroprotective role of curcumin against epilepsy through activation of Bcl-2 family and P38 MAPK pathways. ACS Chem Neurosci 11(13):1985\u20131995. https:\/\/doi.org\/10.1021\/acschemneuro.0c00242","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"11592_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16050637","volume":"16","author":"J Yakubu","year":"2024","unstructured":"Yakubu J, Pandey AV (2024) Innovative delivery systems for curcumin: exploring nanosized and conventional formulations. Pharmaceutics 16(5):637. https:\/\/doi.org\/10.3390\/pharmaceutics16050637","journal-title":"Pharmaceutics"},{"key":"11592_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2024.104660","volume":"61","author":"Y Han","year":"2024","unstructured":"Han Y, Fu S, Yang X, Wang X, Zhao H, Yang X (2024) Recent nanotechnology improvements in curcumin bioavailability and related applications. Food Biosci 61:104660. https:\/\/doi.org\/10.1016\/j.fbio.2024.104660","journal-title":"Food Biosci"},{"issue":"4","key":"11592_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ph18040470","volume":"18","author":"OM Saka","year":"2025","unstructured":"Saka OM, Ayg\u00fcler C, \u00d6zdemir NS, S\u00fcr\u00fcc\u00fc B, \u00c7ak\u0131rl\u0131 E, Nemutlu E, Demirbolat GM (2025) An experimental design approach for producing curcumin-loaded solid lipid nanoparticles. Pharmaceuticals (Basel) 18(4):470. https:\/\/doi.org\/10.3390\/ph18040470","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"11592_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-024-05983-8","volume":"26","author":"A Alqudah","year":"2024","unstructured":"Alqudah A, Aljabali AAA, Gammoh O, Tambuwala MM (2024) Advancements in neurotherapeutics: nanoparticles overcoming the blood\u2013brain barrier for precise CNS targeting. J Nanopart Res 26(6):123. https:\/\/doi.org\/10.1007\/s11051-024-05983-8","journal-title":"J Nanopart Res"},{"issue":"9","key":"11592_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17091169","volume":"17","author":"L N\u00e1jera-Maldonado","year":"2025","unstructured":"N\u00e1jera-Maldonado L, Parra-Gonz\u00e1lez M, Peralta-Cuevas E, Gutierrez-Onofre AJ, Garcia-Atutxa I, Villanueva-Flores F (2025) Cracking the blood\u2013brain barrier code: rational nanomaterial design for next-generation neurological therapies. Pharmaceutics 17(9):1169. https:\/\/doi.org\/10.3390\/pharmaceutics17091169","journal-title":"Pharmaceutics"},{"key":"11592_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1531288","volume":"15","author":"S Khatoon","year":"2025","unstructured":"Khatoon S, Kalam N (2025) Mechanistic insight of curcumin: a potential pharmacological candidate for epilepsy. Front Pharmacol 15:1531288. https:\/\/doi.org\/10.3389\/fphar.2024.1531288","journal-title":"Front Pharmacol"},{"key":"11592_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113595","volume":"381","author":"H Baghirov","year":"2025","unstructured":"Baghirov H (2025) Mechanisms of receptor-mediated transcytosis at the blood\u2013brain barrier. J Control Release 381:113595. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113595","journal-title":"J Control Release"},{"issue":"3","key":"11592_CR39","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","volume":"18","author":"S Zha","year":"2024","unstructured":"Zha S, Liu H, Li H, Li H, Wong KL, All AH (2024) Functionalized nanomaterials capable of crossing the blood\u2013brain barrier. ACS Nano 18(3):1820\u20131845. https:\/\/doi.org\/10.1021\/acsnano.3c10674","journal-title":"ACS Nano"},{"issue":"3","key":"11592_CR40","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s44222-023-00138-1","volume":"2","author":"H Cabral","year":"2024","unstructured":"Cabral H, Li J, Miyata K, Kataoka K (2024) Controlling the biodistribution and clearance of nanomedicines. Nat Rev Bioeng 2(3):214\u2013232. https:\/\/doi.org\/10.1038\/s44222-023-00138-1","journal-title":"Nat Rev Bioeng"},{"issue":"4","key":"11592_CR41","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/epd2.20069","volume":"25","author":"C Johannessen Landmark","year":"2023","unstructured":"Johannessen Landmark C, Eyal S, Burns ML, Franco V, Johannessen SI (2023) Pharmacological aspects of antiseizure medications: from basic mechanisms to clinical considerations of drug interactions and use of therapeutic drug monitoring. Epileptic Disord 25(4):454\u2013471. https:\/\/doi.org\/10.1002\/epd2.20069","journal-title":"Epileptic Disord"},{"key":"11592_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.chaos.2025.116677","volume":"199","author":"B Hu","year":"2025","unstructured":"Hu B, Wang X, Ying X, Zhao J (2025) Dynamical modeling reveals the pivotal regulatory role of direct glutamatergic subthalamic-striatal projections in modulating basal ganglia activity during absence epilepsy. Chaos Solitons Fractals 199:116677. https:\/\/doi.org\/10.1016\/j.chaos.2025.116677","journal-title":"Chaos Solitons Fractals"},{"key":"11592_CR43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1109\/TNSRE.2023.3346955","volume":"32","author":"S Shi","year":"2024","unstructured":"Shi S, Liu W (2024) B2-ViT net: broad vision transformer network with broad attention for seizure prediction. IEEE Trans Neural Syst Rehabil Eng 32:178\u2013188. https:\/\/doi.org\/10.1109\/TNSRE.2023.3346955","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"key":"11592_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2025.112366","volume":"621","author":"B Hu","year":"2026","unstructured":"Hu B, Peng J, Li W, Xiao Y, Zhu N (2026) Deciphering the modulatory role of direct pedunculopontine nucleus-cortical circuitry in absence seizure dynamics: a computational study. J Theor Biol 621:112366. https:\/\/doi.org\/10.1016\/j.jtbi.2025.112366","journal-title":"J Theor Biol"},{"key":"11592_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-00182-4","volume":"15","author":"J Sun","year":"2025","unstructured":"Sun J, Chen Q, Zhuang C, Zhang L, Zhang H, Chen B, Wang Y (2025) Mechanistic insights into synergistic effects using coupled PK-PD modeling. Sci Rep 15:15631. https:\/\/doi.org\/10.1038\/s41598-025-00182-4","journal-title":"Sci Rep"},{"key":"11592_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.pbb.2011.05.011","volume":"99","author":"KH Reeta","year":"2011","unstructured":"Reeta KH, Mehla J, Pahuja M, Gupta YK (2011) Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. Pharmacol Biochem Behav 99:399\u2013407. https:\/\/doi.org\/10.1016\/j.pbb.2011.05.011","journal-title":"Pharmacol Biochem Behav"},{"key":"11592_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106547","volume":"104","author":"APS Chauhan","year":"2025","unstructured":"Chauhan APS, Unnithan D, Alam R, Singh H, Parveen R, Gull A, Khan S, Ali J (2025) Frontiers in therapeutic interventions for epilepsy: nanocarriers as a pivotal catalyst in the synergistic combination of conventional antiepileptics and herbal drugs. J Drug Deliv Sci Technol 104:106547. https:\/\/doi.org\/10.1016\/j.jddst.2024.106547","journal-title":"J Drug Deliv Sci Technol"},{"issue":"8","key":"11592_CR48","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1007\/s11033-020-05538-9","volume":"47","author":"P Kumar","year":"2020","unstructured":"Kumar P, Sharma D (2020) Ameliorative effect of curcumin on altered expression of CACNA1A and GABRD in the pathogenesis of FeCl3-induced epilepsy. Mol Biol Rep 47(8):5699\u20135710. https:\/\/doi.org\/10.1007\/s11033-020-05538-9","journal-title":"Mol Biol Rep"},{"key":"11592_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.eplepsyres.2018.12.007","volume":"150","author":"V Kumar","year":"2019","unstructured":"Kumar V, Prakash C, Singh R, Sharma D (2019) Curcumin\u2019s antiepileptic effect, and alterations in Nav1.1 and Nav1.6 expression in iron-induced epilepsy. Epilepsy Res 150:7\u201316. https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.12.007","journal-title":"Epilepsy Res"},{"issue":"3","key":"11592_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ph18030382","volume":"18","author":"AD Ciubotaru","year":"2025","unstructured":"Ciubotaru AD, Leferman CE, Ignat BE et al (2025) Behavioral and biochemical insights into the therapeutic potential of mitocurcumin in a zebrafish-pentylenetetrazole (PTZ) epilepsy model. Pharmaceuticals (Basel) 18(3):382. https:\/\/doi.org\/10.3390\/ph18030382","journal-title":"Pharmaceuticals (Basel)"},{"issue":"21","key":"11592_CR51","doi-asserted-by":"publisher","first-page":"22754","DOI":"10.1021\/acsomega.4c00825","volume":"9","author":"N Zhang","year":"2024","unstructured":"Zhang N, Lin R, Xu H, Jing X, Zhou H, Wen X, Xie Q (2024) Identification of curcumin targets in the brain of epileptic mice using DARTS. ACS Omega 9(21):22754\u201322763. https:\/\/doi.org\/10.1021\/acsomega.4c00825","journal-title":"ACS Omega"},{"issue":"9","key":"11592_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ph16091223","volume":"16","author":"MN Alam","year":"2023","unstructured":"Alam MN, Singh L, Khan NA et al (2023) Ameliorative effect of ethanolic extract of Moringa oleifera leaves in combination with curcumin against PTZ-induced kindled epilepsy in rats: in vivo and in silico. Pharmaceuticals (Basel) 16(9):1223. https:\/\/doi.org\/10.3390\/ph16091223","journal-title":"Pharmaceuticals (Basel)"},{"key":"11592_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.884813","volume":"16","author":"CP Nascimento","year":"2022","unstructured":"Nascimento CP, Ferreira LO, da Silva ALM et al (2022) A combination of Curcuma longa and diazepam attenuates seizures and subsequent hippocampal neurodegeneration. Front Cell Neurosci 16:884813. https:\/\/doi.org\/10.3389\/fncel.2022.884813","journal-title":"Front Cell Neurosci"},{"key":"11592_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2022.106873","volume":"181","author":"CM Drion","year":"2022","unstructured":"Drion CM, Kooijman L, Chan D, Berkhout J, van Vliet EA, Wadman WJ, Gorter JA (2022) No persistent effects of intracerebral curcumin administration on seizure progression and neuropathology in the kindling rat model for temporal lobe epilepsy. Epilepsy Res 181:106873. https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106873","journal-title":"Epilepsy Res"},{"key":"11592_CR55","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.lfs.2018.09.007","volume":"211","author":"A Arbabi Jahan","year":"2018","unstructured":"Arbabi Jahan A, Rad A, Ghanbarabadi M, Amin B, Mohammad-Zadeh M (2018) The role of serotonin and its receptors on the anticonvulsant effect of curcumin in pentylenetetrazol-induced seizures. Life Sci 211:252\u2013260. https:\/\/doi.org\/10.1016\/j.lfs.2018.09.007","journal-title":"Life Sci"},{"key":"11592_CR56","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neulet.2017.05.018","volume":"651","author":"A Aminirad","year":"2017","unstructured":"Aminirad A, Mousavi SE, Fakhraei N, Mousavi SM, Rezayat SM (2017) The role of nitric oxide in anticonvulsant effect of nanocurcumine on pentylenetetrazole-induced seizure in mice. Neurosci Lett 651:226\u2013231. https:\/\/doi.org\/10.1016\/j.neulet.2017.05.018","journal-title":"Neurosci Lett"},{"key":"11592_CR57","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.brainresbull.2018.08.010","volume":"142","author":"SR Mansoor","year":"2018","unstructured":"Mansoor SR, Hashemian M, Khalili-Fomeshi M, Ashrafpour M, Moghadamnia AA, Ghasemi-Kasman M (2018) Upregulation of klotho and erythropoietin contributes to the neuroprotection induced by curcumin-loaded nanoparticles in experimental model of chronic epilepsy. Brain Res Bull 142:281\u2013288. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.08.010","journal-title":"Brain Res Bull"},{"issue":"1","key":"11592_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20897-x","volume":"8","author":"KT Bertoncello","year":"2018","unstructured":"Bertoncello KT, Aguiar GPS, Oliveira JV, Siebel AM (2018) Micronization potentiates curcumin\u2019s anti-seizure effect and brings an important advance in epilepsy treatment. Sci Rep 8(1):2645. https:\/\/doi.org\/10.1038\/s41598-018-20897-x","journal-title":"Sci Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11592-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11592-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11592-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:57:25Z","timestamp":1773320245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11592-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11592"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11592-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical issues (including plagiarism, data fabrication, double publication) have been completely observed by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"486"}}